Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
CONTENTS